Article

Comparison of Metabolic Dysfunction-Associated Fatty Liver Disease with Non-Alcoholic Fatty Liver Disease in Identifying Cardiovascular Risk in Chinese Individuals with Rheumatoid Arthritis

2022-02-16

Abstract excerpt

<h4>Background: </h4> The nomenclature from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) is considered to identify more cardiovascular disease (CVD) risk in general population, and patients with rheumatoid arthritis (RA) carry an excess risk for CVD. We aimed to compare MAFLD with NAFLD in identifying CVD risk in RA patients. <h4>Methods: </h4>: Clinical...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 36d4bb55-2450-5a96-9ebc-96b685be767a
DOI: 10.21203/rs.3.rs-1352019/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparison of Metabolic Dysfunction-Associated Fatty Liver Disease with Non-Alcoholic Fatty Liver Disease in Identifying Cardiovascular Risk in Chinese Individuals with Rheumatoid ArthritisDOI 10.21203/rs.3.rs-1352019/v1Read

Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional studySemantic proximity Read

A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in ChinaSemantic proximity Read

The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese PopulationSemantic proximity Read

PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD.Semantic proximity Read

External Validation and Comparison of Simple Tools to Screen for Nonalcoholic Fatty Liver disease in Chinese community populationSemantic proximity Read

The Effect of Cardiometabolic Drugs on Non-Alcoholic Fatty Liver Disease (NAFLD), Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Semantic proximity Read

Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.Semantic proximity Read

[Precise clinical classification of metabolic associated fatty liver disease].Semantic proximity Read

Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosisSemantic proximity Read

The New Paradigm of Non-Alcoholic Fatty Liver Disease: Phenotypic Diversity of Metabolically Associated Fatty Liver DiseaseSemantic proximity Read

Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with InflammationSemantic proximity Read

Is UA/HDL-C a Reliable Surrogate Marker for Fatty Liver? A Comparative Evaluation with Metabolic Scores in a Mexican Population: The Genetics of Atherosclerotic Disease StudySemantic proximity Read